PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 27419352-0 2001 Methimazole-Induced Agranulocytosis and Quick Recovery with G-CSF. Methimazole 0-11 colony stimulating factor 3 Homo sapiens 60-65 18528228-0 2008 Methimazole-induced severe febrile neutropenia responding to recombinant human granulocyte colony stimulating factor. Methimazole 0-11 colony stimulating factor 3 Homo sapiens 79-116 16553037-0 2006 Successful treatment of methimazole-induced severe aplastic anemia with recombinant human granulocyte colony-stimulating factor and high-dosage steroids. Methimazole 24-35 colony stimulating factor 3 Homo sapiens 90-127 27419352-4 2001 We think that in patients with methimazole-induced agranulocytosis, G-CSF may reduce the risk and severity of infection and in some cases should be accepted as a part of the standard therapy. Methimazole 31-42 colony stimulating factor 3 Homo sapiens 68-73 15251798-0 1997 Recombinant human granulocyte colony-stimulating factor in treatment of methimazole-induced agranulocytosis. Methimazole 72-83 colony stimulating factor 3 Homo sapiens 18-55 9803142-5 1998 In the second case we report the use of granulocyte colony-stimulating factor (G-CSF) for treatment of a patient with methimazole-induced granulocytopenia. Methimazole 118-129 colony stimulating factor 3 Homo sapiens 40-77 9803142-5 1998 In the second case we report the use of granulocyte colony-stimulating factor (G-CSF) for treatment of a patient with methimazole-induced granulocytopenia. Methimazole 118-129 colony stimulating factor 3 Homo sapiens 79-84 9777751-0 1998 Methimazole-induced aplastic anemia in third exposure: successful treatment with recombinant human granulocyte colony-stimulating factor. Methimazole 0-11 colony stimulating factor 3 Homo sapiens 99-136 15251798-1 1997 OBJECTIVE: To describe a patient with methimazole-induced agranulocytosis who was treated with recombinant human granulocyte colony-stimulating factor (G-CSF). Methimazole 38-49 colony stimulating factor 3 Homo sapiens 113-150 15251798-1 1997 OBJECTIVE: To describe a patient with methimazole-induced agranulocytosis who was treated with recombinant human granulocyte colony-stimulating factor (G-CSF). Methimazole 38-49 colony stimulating factor 3 Homo sapiens 152-157 7542790-0 1995 Methimazole agranulocytosis treated with recombinant human granulocyte colony stimulating factor. Methimazole 0-11 colony stimulating factor 3 Homo sapiens 59-96 8605651-0 1995 Methimazole-induced agranulocytosis treated with recombinant human granulocyte colony-stimulating factor (rhG-CSF): a case report. Methimazole 0-11 colony stimulating factor 3 Homo sapiens 67-104 7522068-6 1994 Since agranulocytosis is considered to be a severe and fatal complication of methimazole therapy, treatment with granulocyte colony stimulating factor seems to be useful for this life-threatening condition. Methimazole 77-88 colony stimulating factor 3 Homo sapiens 113-150 7530522-0 1994 Methimazole-induced agranulocytosis treated with recombinant human granulocyte colony-stimulating factor (G-CSF). Methimazole 0-11 colony stimulating factor 3 Homo sapiens 67-104 7530522-0 1994 Methimazole-induced agranulocytosis treated with recombinant human granulocyte colony-stimulating factor (G-CSF). Methimazole 0-11 colony stimulating factor 3 Homo sapiens 106-111 7521347-0 1993 Treatment of methimazole-induced agranulocytosis using recombinant human granulocyte colony-stimulating factor (rhG-CSF). Methimazole 13-24 colony stimulating factor 3 Homo sapiens 73-110 27408395-0 2016 Methimazole Induced Total Myeloid Aplasia with Delayed Recovery Despite Granulocyte Colony Stimulating Factor (G-CSF): Marrow Progenitor Recovery Kinetics. Methimazole 0-11 colony stimulating factor 3 Homo sapiens 72-109 1281122-0 1992 [Change in serum G-CSF levels in patients with Graves" disease by treatment with methimazole]. Methimazole 81-92 colony stimulating factor 3 Homo sapiens 17-22 1281122-1 1992 We evaluated the determination of serum G-CSF in the diagnosis of granulocytopenia due to methimazole (MMI) in 54 patients with Graves" disease, while they were being treated with MMI, by way of measuring WBC counts and serum levels of G-CSF, thyroid hormones, IgE, and interleukin-2. Methimazole 90-101 colony stimulating factor 3 Homo sapiens 40-45 2672934-0 1989 Methimazole-induced agranulocytosis and granulocyte-colony stimulating factor. Methimazole 0-11 colony stimulating factor 3 Homo sapiens 40-77 29026576-0 2017 Use of granulocyte colony-stimulating factor in the treatment of methimazole-induced agranulocytosis: a case report. Methimazole 65-76 colony stimulating factor 3 Homo sapiens 7-44 27408395-0 2016 Methimazole Induced Total Myeloid Aplasia with Delayed Recovery Despite Granulocyte Colony Stimulating Factor (G-CSF): Marrow Progenitor Recovery Kinetics. Methimazole 0-11 colony stimulating factor 3 Homo sapiens 111-116